OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 154
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 154
Showing 26-50 of 154 citing articles:
Nano‐biotechnology in tumour and cancerous disease: A perspective review
Ambikesh Soni, Manohar Prasad Bhandari, Gagan Kant Tripathi, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 6, pp. 737-762
Open Access | Times Cited: 34
Ambikesh Soni, Manohar Prasad Bhandari, Gagan Kant Tripathi, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 6, pp. 737-762
Open Access | Times Cited: 34
Rationally designed multifunctional nanoparticles as GSH-responsive anticancer drug delivery systems based on host-guest polymers derived from dextran and β-cyclodextrin
Xichuan Tang, Yuting Wen, Zhongxing Zhang, et al.
Carbohydrate Polymers (2023) Vol. 320, pp. 121207-121207
Closed Access | Times Cited: 28
Xichuan Tang, Yuting Wen, Zhongxing Zhang, et al.
Carbohydrate Polymers (2023) Vol. 320, pp. 121207-121207
Closed Access | Times Cited: 28
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 15
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 15
From Taxus to paclitaxel: Opportunities and challenges for urban agriculture to promote human health
Xiulan Xie, Yaohua Zhai, Hao Cheng, et al.
Plant Physiology and Biochemistry (2025) Vol. 220, pp. 109502-109502
Closed Access | Times Cited: 1
Xiulan Xie, Yaohua Zhai, Hao Cheng, et al.
Plant Physiology and Biochemistry (2025) Vol. 220, pp. 109502-109502
Closed Access | Times Cited: 1
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody
Jinguan Lin, Song Qu, Kunyu Yang, et al.
Cancer Letters (2025), pp. 217513-217513
Closed Access | Times Cited: 1
Jinguan Lin, Song Qu, Kunyu Yang, et al.
Cancer Letters (2025), pp. 217513-217513
Closed Access | Times Cited: 1
H1.0 modulates IL-6 expression and paclitaxel resistance via HDAC5 in ovarian cancer cells
Shang‐Lang Huang, Ting‐Chang Chang, Nian‐Kang Sun
Biochemical Pharmacology (2025), pp. 116876-116876
Closed Access | Times Cited: 1
Shang‐Lang Huang, Ting‐Chang Chang, Nian‐Kang Sun
Biochemical Pharmacology (2025), pp. 116876-116876
Closed Access | Times Cited: 1
Dioscin: A review on pharmacological properties and therapeutic values
Shinjini Bandopadhyay, Uttpal Anand, Vijaykumar Shivaji Gadekar, et al.
BioFactors (2021) Vol. 48, Iss. 1, pp. 22-55
Closed Access | Times Cited: 42
Shinjini Bandopadhyay, Uttpal Anand, Vijaykumar Shivaji Gadekar, et al.
BioFactors (2021) Vol. 48, Iss. 1, pp. 22-55
Closed Access | Times Cited: 42
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 32
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 32
Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update
Swaroop Kumar Pandey, Uttpal Anand, Waseem Ahmad Siddiqui, et al.
Advances in Medicine (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 22
Swaroop Kumar Pandey, Uttpal Anand, Waseem Ahmad Siddiqui, et al.
Advances in Medicine (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 22
Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles
Qingyu Lu, Wenhao Gao, Zhenzhen Chen, et al.
International Journal of Pharmaceutics (2024) Vol. 655, pp. 124028-124028
Closed Access | Times Cited: 7
Qingyu Lu, Wenhao Gao, Zhenzhen Chen, et al.
International Journal of Pharmaceutics (2024) Vol. 655, pp. 124028-124028
Closed Access | Times Cited: 7
Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study
Jiaming Gao, Jingwen Cheng, Wanyu Xie, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 639-651
Closed Access | Times Cited: 6
Jiaming Gao, Jingwen Cheng, Wanyu Xie, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 639-651
Closed Access | Times Cited: 6
Development and Application of Cationic Nile Blue Probes in Live-Cell Super-Resolution Imaging and Specific Targeting to Mitochondria
Yunsheng Li, Xiaoyu Bai, Dan Yang
ACS Central Science (2024) Vol. 10, Iss. 6, pp. 1221-1230
Open Access | Times Cited: 6
Yunsheng Li, Xiaoyu Bai, Dan Yang
ACS Central Science (2024) Vol. 10, Iss. 6, pp. 1221-1230
Open Access | Times Cited: 6
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 6
The Battlefield of Chemotherapy in Pediatric Cancers
Letao Bo, Youyou Wang, Yidong Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1963-1963
Open Access | Times Cited: 16
Letao Bo, Youyou Wang, Yidong Li, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1963-1963
Open Access | Times Cited: 16
Nanoparticle-Based Combination Therapy for Ovarian Cancer
Yingli Wu, Yu Yang, Xiaolin Lv, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1965-1987
Open Access | Times Cited: 15
Yingli Wu, Yu Yang, Xiaolin Lv, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1965-1987
Open Access | Times Cited: 15
Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells
Heming Zhao, Liming Gong, Hao Wu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1874-1874
Open Access | Times Cited: 15
Heming Zhao, Liming Gong, Hao Wu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1874-1874
Open Access | Times Cited: 15
Therapeutic potential and industrial applications of Terminalia arjuna bark
Vikas Kumar, Nitin Sharma, Rakshandha Saini, et al.
Journal of Ethnopharmacology (2023) Vol. 310, pp. 116352-116352
Closed Access | Times Cited: 13
Vikas Kumar, Nitin Sharma, Rakshandha Saini, et al.
Journal of Ethnopharmacology (2023) Vol. 310, pp. 116352-116352
Closed Access | Times Cited: 13
Paclitaxel combined with Compound K inducing pyroptosis of non-small cell lung cancer cells by regulating Treg/Th17 balance
Hongzheng Wang, Min Huang, Mengyuan Zhu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Hongzheng Wang, Min Huang, Mengyuan Zhu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
The role of kinesin family members in hepatobiliary carcinomas: from bench to bedside
Kai Zhao, Xiangyu Li, Yunxiang Feng, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Kai Zhao, Xiangyu Li, Yunxiang Feng, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors
Xin Yang, Yifan Wang, Si Chen, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7051-7069
Open Access | Times Cited: 28
Xin Yang, Yifan Wang, Si Chen, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7051-7069
Open Access | Times Cited: 28
Natural Taxanes: From Plant Composition to Human Pharmacology and Toxicity
Ľuboš Nižňanský, Denisa Osinová, Roman Kuruc, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15619-15619
Open Access | Times Cited: 22
Ľuboš Nižňanský, Denisa Osinová, Roman Kuruc, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15619-15619
Open Access | Times Cited: 22
Smart Lipid‐Based Nanoparticles in Lung Cancer Treatment: Current Status and Future Directions
Ramin Yousefpour Shahrivar, Zahra Ahmadi Fakhr, Elham Abbasgholinejad, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Closed Access | Times Cited: 12
Ramin Yousefpour Shahrivar, Zahra Ahmadi Fakhr, Elham Abbasgholinejad, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Closed Access | Times Cited: 12
The prognostic gene CRABP2 affects drug sensitivity by regulating docetaxel-induced apoptosis in breast invasive carcinoma: A pan-cancer analysis
Shuangshuang Zeng, Zhijie Xu, Qiuju Liang, et al.
Chemico-Biological Interactions (2023) Vol. 373, pp. 110372-110372
Closed Access | Times Cited: 11
Shuangshuang Zeng, Zhijie Xu, Qiuju Liang, et al.
Chemico-Biological Interactions (2023) Vol. 373, pp. 110372-110372
Closed Access | Times Cited: 11
Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights
Pratikshya Sa, Priyanka Mohapatra, Shasank S. Swain, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 11, pp. 5254-5277
Closed Access | Times Cited: 11
Pratikshya Sa, Priyanka Mohapatra, Shasank S. Swain, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 11, pp. 5254-5277
Closed Access | Times Cited: 11
